Not-For-Profit Models Needed For Commercially Unviable Rare Disease Drugs

Developing drugs for some rare diseases is “just not commercially feasible,” meaning that alternative approaches, such as funding through venture philanthropy and not-for-profit models, need to be explored, a gene therapy professor has said.